Philipps-Universität Marburg

Post-marketing Experience with Cenobamate in the Treatment of Focal Epilepsies: A Multicentre Cohort Study (2025) Strzelczyk A, von Podewils F, Hamer H, Knake S, Rosenow F, Klotz KA, Kurlemann G, et al. Journal article Time-resolved photoelectron spectroscopy at surfaces (2025) Aeschlimann M, Bange JP, Bauer M, Bovensiepen U, Elmers HJ, Fauster T, Gierster L, et al. Journal article The surface chemical bond of a nonbenzenoid aromatic hydrocarbon: Acepleiadylene versus pyrene (2025) Ruppenthal L, Ruan Z, Schramm J, Liu P, Münster F, Naumann T, Neuhaus L, et al. Journal article Dynamics of molecular heterogeneity in high-risk luminal breast cancer—From intrinsic to adaptive subtyping (2025) Denkert C, Rachakonda S, Karn T, Weber K, Martin M, Marmé F, Untch M, et al. Journal article Corrigendum to “The impact of photovoice on the report of emotions in individuals with persistent physical symptoms: Results of an experimental trial” [Journal of Psychosomatic Research 191 (2025) 112069] (Journal of Psychosomatic Research (2025) 191, (S0022399925000339), (10.1016/j.jpsychores.2025.112069)) (2025) Studer S, Nuhn C, Weise C, Kleinstäuber M Journal article, Erratum The IKZF1 N159S mutation is associated with poor outcome and a distinct molecular profile in adult patients with AML (2025) Stasik S, Eckardt JN, Röllig C, Baldus CD, Platzbecker U, Serve H, Müller-Tidow C, et al. Journal article DSM-5 genito-pelvic pain/penetration disorder: Prevalence, comorbidities, and associated factors in university students (2025) Zarski AC, Baumeister H, Kählke F Journal article A Conversation on Aesthetics and Affects of Power (2025) Aschenbrenner L, Lange G, Terk M, Aschenbrenner L Journal article A Fluorescent Probe Enables the Discovery of Improved Antagonists Targeting the Intracellular Allosteric Site of the Chemokine Receptor CCR7 (2025) Wurnig SL, Huber M, Weiler C, Baltrukevich H, Merten N, Stötzel I, Steffen T, et al. Journal article A multicenter cohort study on the efficacy, retention, and tolerability of cenobamate in patients with developmental and epileptic encephalopathies (2025) Buhleier E, Schubert-Bast S, Knake S, von Podewils F, Hamer H, Melzer N, Kurlemann G, et al. Journal article